A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease

Citation
Jl. Anderson et al., A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease, J AM COL C, 36(4), 2000, pp. 1248-1252
Citations number
17
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN journal
0735-1097 → ACNP
Volume
36
Issue
4
Year of publication
2000
Pages
1248 - 1252
Database
ISI
SICI code
0735-1097(200010)36:4<1248:ACVOTA>2.0.ZU;2-W
Abstract
OBJECTIVE We tested whether a common AMPD1 gene variant is associated with improved cardiovascular (CV) survival in patients with coronary artery dise ase (CAD). BACKGROUND Reduced activity of adenosine monophosphate deaminase (AMPD) may increase production of adenosine, a cardioprotective agent. A common, nons ense, point variant of the AMPD1 gene (C34T) results in enzymatic inactivit y and has been associated with prolonged survival in heart failure. METHODS Blood was collected from 367 patients undergoing coronary angiograp hy. Genotyping was done by polymerase chain reaction amplification and rest riction enzyme digestion, resulting in allele-specific fragments. Coronary artery disease was defined as greater than or equal to 70% stenosis pf grea ter than or equal to 1 coronary artery. Patients were followed prospectivel y for up to 4.8 years. Survival statistics compared hetero- (+/-) or homozy gotic (-/-) carriers with noncarriers. RESULTS Patients were 66 +/- 10 years old; 79% were men; 22.6% were heteroz ygous and 1.9% homozygous for the variant AMPD1(-) allele. During a mean of 3.5 +/- 1.0 years, 52 patients (14.2%) died, 37 (10.1%) of CV causes. Card iovascular mortality was 4.4% (4/90) in AMPD1(-) allele carriers compared w ith 11.9% (33/277) in noncarriers (p = 0.046). In multiple variable regress ion analysis, only age (hazard ratio, 1.11/year, p < 0.001) and AMPD1(-) ca rriage (hazard ratio, 0.36, p = 0.053) were independent predictors of CV mo rtality. CONCLUSIONS Carriage of a common variant of the AMPD1 gene was associated w ith improved CV survival in patients with angiographically documented CAD. The dysfunctional AMPD1(-) allele may lead to increased cardiac adenosine a nd increased cardioprotection during ischemic events. Adenosine monophospha te deaminase-l genotyping should be further explored in CAD for prognostic, mechanistic and therapeutic insights. (J Am Coil Cardiol 2000;36: 1248-52) (C) 2000 by the American College of Cardiology.